US 6,635,751 B1 · Isolated nucleic acids encoding activated and suppressive forms of ATF6

Abstract

A factor capable of efficiently regulating expression of an endoplasmic chaperone gene, a nucleic acid encoding it, a complementary strand nucleic acid thereof, a method for regulating expression of an endoplasmic reticulum chaperone gene, and a method for expressing a foreign gene is provided. The endoplasmic reticulum stress transcription factor is capable of regulating transcription-inducing activity, wherein the transcription-inducing activity is exhibited by an element having the nucleotide sequence shown in SEQ ID NO:1 or an element having a nucleotide sequence resulting from substitution of 1 to 3 bases with other bases in the nucleotide sequence as shown in SEQ ID NO:1. A method for controlling expression of an endoplasmic reticulum chaperone, comprising expressing the factor; a method for expressing a foreign protein, comprising positively regulating expression of an endoplasmic reticulum chaperone gene by the method for controlling expression; and a nucleic acid encoding activated form of ATF6, activated form of CREB-RP, suppressive form of ATF6, or suppressive form of CREB-RP, or the complementary strand thereto are also provided. It is expected to be applied to treatment or prophylaxis of cancers, arteriosclerosis, cystic fibrosis, ischemic diseases, wounds or ulcers.

Claims2

Dependent claims

An isolated nucleic acid encoding an activated form of ATF6, or the complementary strand thereto, wherein said activated form of ATF6 is p50ATF6 resulting from processing by endoplasmic reticulum stress, a polypeptide obtainable by expression of DNA encoding p50ATF6, or a polypeptide comprising a region of 1st to 373rd amino acids or a region of 1st to 366th amino acids in ATF6, and wherein said nucleic acid is selected from the group consisting of:

(a) a nucleic acid having a nucleotide sequence encoding an amino acid sequence as shown in amino acid numbers:
1 to 373 in SEQ ID NO:
32;
(b) a nucleic acid having a nucleotide sequence encoding an amino acid sequence as shown in amino acid numbers:
1 to 366 in SEQ ID NO:
32;
(c) a nucleic acid having a nucleotide sequence as shown in base numbers:
69 to 1187 in SEQ ID NO:
31;
(d) a nucleic acid having a nucleotide sequence as shown in base numbers:
69 to 1166 in SEQ ID NO:
31;
and
(e) a nucleic acid capable of hybridizing to a strand complementary to the nucleic acid of any one of (a) to (d) under stringent conditions at 68° C. in aqueous with 6×sodium chloride-sodium citrate (SSC) or 42° C. in 50% formamide with 6×SSC, wherein said nucleic acid encoding an activated form of ATF6 encodes a polypeptide showing an activity for enhancing expression of endoplasmic reticulum chaperone genes without conversion of the polypeptide in the presence of endoplasmic reticulum stress, or the complementary strand thereto.

11 more elements

An isolated nucleic acid encoding a suppressive form of ATF6, or the complementary strand thereto, wherein said suppressive form of ATF6 is a polypeptide resulting from disruption of a region of 1st to 150th amino acids in ATF6, or a polypeptide resulting from disruption of a region of 1st to 150th amino acids in an activated form of ATF6 selected from the group consisting of:

(i) p50ATF6 resulting from processing by endoplasmic reticulum stress, (ii) a polypeptide obtainable by expression of DNA encoding p50ATF6, and (iii) a polypeptide comprising a region of 1st to 373rd amino acids or a region of 1st to 366th amino acids in ATF6, and wherein the nucleic acid is selected from the group consisting of:
(1) a nucleic acid having a nucleotide sequence encoding an amino acid sequence as shown in amino acid numbers:
151 to 670 in SEQ ID NO:
32;
(2) a nucleic acid having a nucleotide sequence encoding an amino acid sequence as shown in amino acid numbers:
151 to 373 in SEQ ID NO:
32;
(3) a nucleic acid having a nucleotide sequence encoding an amino acid sequence as shown in amino acid numbers:
151 to 366 in SEQ ID NO:
32;
(4) a nucleic acid having a nucleotide sequence as shown in base numbers:
519 to 2078 in SEQ ID NO:
31;
(5) a nucleic acid having a nucleotide sequence as shown in base numbers:
519 to 1187 in SEQ ID NO:
31;
(6) a nucleic acid having a nucleotide sequence as shown in base numbers:
519 to 1166 in SEQ ID NO:
31;
and
(7) a nucleic acid capable of hybridizing to the strand complementary to the nucleic acid of any one of (1) to (6) under stringent conditions at 68° C. in aqueous with 6×sodium chloride-sodium citrate (SSC) or 42° C. in 50% formamide with 6×SSC, wherein said nucleic acid encoding a suppressive form of ATF6 encodes a polypeptide showing an activity for decreasing expression of endoplasmic reticulum chaperone genes without conversion of a protein in the presence of endoplasmic reticulum stress, or the complementary strand thereto.

18 more elements

Dependencies are inferred from the claim text.

Isolated nucleic acids encoding activated and suppressive forms of ATF6

Life of this patent

Isolated nucleic acids encoding activated and suppressive forms of ATF6

Life of this patent

Abstract

Claims2